They had more HF medications such as β-blockers (SGLT2-I: 73.17% and DPP4-I: 61.24%), ACEIs/ARBs (SGLT2-I: 71.50% and DPP4-I: 63.83%), and MRAs (SGLT2-I: 55.38% and DPP4-I: 41.32%). The gene discussed is SLC5A2; the disease is hydrops fetalis.